These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32422108)

  • 1. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Finucane TE
    Ann Intern Med; 2020 May; 172(10):707. PubMed ID: 32422108
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Park S; Han K; Kim DK
    Ann Intern Med; 2020 May; 172(10):707-708. PubMed ID: 32422106
    [No Abstract]   [Full Text] [Related]  

  • 3. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med; 2019 Dec; 171(12):. PubMed ID: 31766054
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic syndrome, subclinical coronary atherosclerosis, and cardiovascular risk.
    Campbell CY; Nasir K; Blumenthal RS
    Am Heart Hosp J; 2005; 3(2):105-10. PubMed ID: 15860997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B.
    Cheng JY; Wong VW; Tse YK; Chim AM; Chan HL; Wong GL
    Hepatology; 2016 Nov; 64(5):1507-1517. PubMed ID: 27680510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort study.
    Cho YK; Kang YM; Yoo JH; Lee J; Park JY; Lee WJ; Kim YJ; Jung CH
    Metabolism; 2019 Aug; 97():50-56. PubMed ID: 31071310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on “Metabolic syndrome is associated with cardiovascular events in haemodialysis”.
    Esteve-Simo V; Pou-Potau M; Fulquet-Nicolas M; Ramírez-de Arellano M
    Nefrologia; 2014; 34(5):675-6. PubMed ID: 25259821
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular risk associated with the metabolic syndrome.
    Lindsay RS; Howard BV
    Curr Diab Rep; 2004 Feb; 4(1):63-8. PubMed ID: 14764282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status: A Nationwide Population-Based Study of Approximately 10 Million Persons.
    Park S; Lee S; Kim Y; Lee Y; Kang MW; Han K; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    Ann Intern Med; 2019 Dec; 171(12):875-884. PubMed ID: 31766057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes.
    Rosenson RS; Reasner CA
    Curr Opin Cardiol; 2004 Sep; 19(5):480-7. PubMed ID: 15316457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and coronary heart disease equivalent conditions in predicting cardiovascular events in young to middle-aged adults.
    Akosah KO; McHugh VL; Mathiason MA; Kulkarni A; Barnhart SI
    J Cardiometab Syndr; 2006; 1(3):173-7. PubMed ID: 17679809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the metabolic syndrome and imaging of subclinical coronary artery disease: early markers of cardiovascular risk.
    Schoenhagen P; Nissen SE
    J Cardiovasc Nurs; 2006; 21(4):291-7. PubMed ID: 16823283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Managing the cardiovascular risk associated with the metabolic syndrome.
    Montalto G; Rizzo M; Mikhailidis DP
    Curr Pharm Des; 2014; 20(31):4941-3. PubMed ID: 24320029
    [No Abstract]   [Full Text] [Related]  

  • 14. Managing cardiovascular risk inpatients with metabolic syndrome.
    Nesto RW
    Clin Cornerstone; 2005; 7(2-3):46-51. PubMed ID: 16473260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipidaemia and cardiovascular disease: cardiovascular disease and the metabolic syndrome: further research or more implementation?
    Hanna FW
    Curr Opin Lipidol; 2002 Dec; 13(6):697-9. PubMed ID: 12441895
    [No Abstract]   [Full Text] [Related]  

  • 16. Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study.
    Wild SH; Byrne CD; Smith FB; Lee AJ; Fowkes FG
    Diabetes Care; 2006 Mar; 29(3):637-42. PubMed ID: 16505519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study.
    Scuteri A; Najjar SS; Morrell CH; Lakatta EG;
    Diabetes Care; 2005 Apr; 28(4):882-7. PubMed ID: 15793190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence.
    Ford ES
    Diabetes Care; 2005 Jul; 28(7):1769-78. PubMed ID: 15983333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic syndrome: still undefined, but usefull to identify high risk for cardiovascular disease].
    Saad MJ; Zanella MT; Ferreira SR
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):161-2. PubMed ID: 16767281
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin resistance, the metabolic syndrome and risk of cardiovascular disease: a complex story.
    Issa BG; Hanna FW
    Curr Opin Lipidol; 2003 Aug; 14(4):405-7. PubMed ID: 12865741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.